We were able to confirm the finding of increased levels of BAFF mRNA in IBM and PM and could extend the findings to the expression of its ligand APRIL and the chemokines CXCL-12 and 13 in muscle tissue specimens of patients with IBM and PM. The gene discussed is TNFSF13; the disease is inclusion body myositis.